is there withdrawal from semaglutide Navigating the Challenges of Symptoms Two Years After Stopping GLP-1s,

Change the injection spot each week

Semaglutide is approved under a separate brand name, Wegovy, specifically for chronic weight management in adults with obesity or overweight with related health conditions

When food enters the gastrointestinal tract, GLP-1 is released into the bloodstream in response to nutrient intake, particularly carbohydrates and fats

Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: a global retrospective cohort study

Both medications produce weight loss even without significant dietary changes due to their powerful appetite suppression effects